Antithrombotic therapy for patients with total artificial hearts.
作者信息
Volod Oksana, Lam Lee D, Arabia Francisco A
机构信息
Advanced Heart Program, Banner University Medical Group, Phoenix, AZ, USA.
出版信息
Ann Cardiothorac Surg. 2020 Mar;9(2):110-112. doi: 10.21037/acs.2019.12.01.
Abstract
摘要
相似文献
1
Antithrombotic therapy for patients with total artificial hearts.全人工心脏患者的抗栓治疗。
Ann Cardiothorac Surg. 2020 Mar;9(2):110-112. doi: 10.21037/acs.2019.12.01.
2
Pathologic analysis of 34 explanted symbion ventricular assist devices and 10 explanted Jarvik-7 total artificial hearts.
Cardiovasc Pathol. 1993 Jul-Sep;2(3):187-97. doi: 10.1016/1054-8807(93)90002-J. Epub 2004 Apr 22.
3
Multi-Targeted Antithrombotic Therapy for Total Artificial Heart Device Patients.全人工心脏装置患者的多靶点抗血栓治疗
J Extra Corpor Technol. 2016 Mar;48(1):27-34.
4
Summary of the clinical use of the Symbion total artificial heart: a registry report.共生全人工心脏临床应用总结：一项注册报告
J Heart Lung Transplant. 1992 Jan-Feb;11(1 Pt 1):103-16.
5
Summary of the world experience with clinical use of total artificial hearts as heart support devices.作为心脏支持装置的全人工心脏临床应用的全球经验总结。
J Heart Transplant. 1986 May-Jun;5(3):229-35.
6
Total artificial hearts: past, present, and future.全人工心脏：过去、现在和未来。
Nat Rev Cardiol. 2015 Oct;12(10):609-17. doi: 10.1038/nrcardio.2015.79. Epub 2015 Jun 2.
7
Perioperative management of antithrombotic treatment during implantation or revision of cardiac implantable electronic devices: the European Snapshot Survey on Procedural Routines for Electronic Device Implantation (ESS-PREDI).心脏植入式电子设备植入或翻修期间抗栓治疗的围手术期管理：欧洲电子设备植入程序常规快照调查（ESS-PREDI）。
Europace. 2016 May;18(5):778-84. doi: 10.1093/europace/euw127.
8
Rationale, study design, and pilot phase of tHE Management of AntiThrOMbotic therApy (HEMATOMA) in patients undergoing electrophysiological device surgery: Italian National Multicenter Observational REgistry.抗血栓治疗（HEMATOMA）管理的理由、研究设计和试验阶段：在接受电生理设备手术的患者中：意大利国家多中心观察性登记研究。
J Cardiovasc Med (Hagerstown). 2017 Nov;18(11):897-899. doi: 10.2459/JCM.0000000000000534.
9
[Implantable artificial heart].[植入式人工心脏]
Nihon Geka Gakkai Zasshi. 2005 Nov;106(11):694-9.
10
The biocompatibility of artificial organs.人工器官的生物相容性。
ASAIO Trans. 1987 Oct-Dec;33(4):824-33.
引用本文的文献
1
Adverse Events in Total Artificial Heart for End-Stage Heart Failure: Insight From the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE).终末期心力衰竭全人工心脏的不良事件：来自美国食品药品监督管理局制造商和用户设施设备经验（MAUDE）的见解
Int J Heart Fail. 2023 Sep 18;6(2):76-81. doi: 10.36628/ijhf.2023.0020. eCollection 2024 Apr.
2
Experience With SynCardia Total Artificial Heart as a Bridge to Transplantation in 100 Patients.100 例患者应用 SynCardia 全人工心脏作为移植桥的经验。
Ann Thorac Surg. 2023 Mar;115(3):725-732. doi: 10.1016/j.athoracsur.2022.11.034. Epub 2022 Dec 12.
本文引用的文献
1
2
Interagency registry for mechanically assisted circulatory support report on the total artificial heart.机械辅助循环支持机构间注册报告：全人工心脏。
J Heart Lung Transplant. 2018 Nov;37(11):1304-1312. doi: 10.1016/j.healun.2018.04.004. Epub 2018 Apr 26.
3
Factors XI and XII as Targets for New Anticoagulants.作为新型抗凝剂靶点的因子XI和因子XII。
Front Med (Lausanne). 2017 Feb 24;4:19. doi: 10.3389/fmed.2017.00019. eCollection 2017.
4
Role of Thromboelastography Platelet Mapping and International Normalized Ratio in Defining "Normocoagulability" During Anticoagulation for Mechanical Circulatory Support Devices: A Pilot Retrospective Study.血栓弹力图血小板功能分析及国际标准化比值在确定机械循环支持装置抗凝期间“正常凝血状态”中的作用：一项前瞻性回顾性研究
ASAIO J. 2017 Jan/Feb;63(1):24-31. doi: 10.1097/MAT.0000000000000445.
5
Results with SynCardia total artificial heart beyond 1 year.使用SynCardia全人工心脏超过1年的结果。
ASAIO J. 2014 Nov-Dec;60(6):626-34. doi: 10.1097/MAT.0000000000000132.
6
Experience with more than 100 total artificial heart implants.超过 100 例全人工心脏植入的经验。
J Thorac Cardiovasc Surg. 2012 Mar;143(3):727-34. doi: 10.1016/j.jtcvs.2011.12.002. Epub 2012 Jan 14.
7
Haemolysis in patients with ventricular assist devices: major differences between systems.心室辅助装置患者的溶血：各系统间的主要差异。
Eur J Cardiothorac Surg. 2009 Sep;36(3):580-4. doi: 10.1016/j.ejcts.2009.04.015. Epub 2009 May 22.
8
Heparin-induced thrombocytopenia in patients with ventricular assist devices: are new prevention strategies required?心室辅助装置患者的肝素诱导的血小板减少症：是否需要新的预防策略？
Ann Thorac Surg. 2009 May;87(5):1633-40. doi: 10.1016/j.athoracsur.2008.10.060.
9
Cardiac replacement with a total artificial heart as a bridge to transplantation.使用全人工心脏进行心脏置换作为移植的桥梁。
N Engl J Med. 2004 Aug 26;351(9):859-67. doi: 10.1056/NEJMoa040186.
10
What price support? Ventricular assist device induced systemic response.什么价格支持？心室辅助装置引起的全身反应。
ASAIO J. 2003 Sep-Oct;49(5):518-26. doi: 10.1097/01.mat.0000085672.42122.49.
Zotero 插件